Skip to main content

Paradigm Biocapital Advisors LP

Location
NEW YORK, NY
Portfolio Value
Mid $2,883,920,399
Diversification
Diversified
Filing Date
Global Rank
#950 / 7,976 ▲ 157
Top Industry
Biotechnology 97.3%
3Y Alpha vs SPY
-3.4%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
16 quarters · since Dec 2021

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+61.7%
SPY
+76.3%
Annualised alpha
-3.4%
Max drawdown
−47.9%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

31 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025
Top Position
15.8%
−3.4 pts
Top 5
49.3%
−6.1 pts
Top 10
69.2%
−4.1 pts
HHI
714
Dec 2022 → Sep 2025 · range 583 – 934
Diversified−157

Portfolio Trend

16 quarters · across all stocks

Sector Breakdown

As of Sep 30, 2025
Sector % Portfolio Value
Healthcare 100.0% $2,883,920,399

Last Quarter's Activity

Export CSV
Sep 30, 2025 vs Jun 30, 2025

Added To

Positions the filer increased
12 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
7 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
9 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
4 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
31 positions · $2,883,920,399 total · as of Sep 30, 2025
Ticker Company Shares Value (USD) % of Portfolio History